Join to View Full Profile
6314 N. Park AveIndianapolis, IN 46220
Phone+1 317-853-0865
Dr. Bangs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Retired from Eli Lilly, March 2025
Education & Training
Indiana University School of MedicineFellowship, Child and Adolescent Psychiatry, 1991 - 1993
Baylor College of MedicineResidency, Psychiatry, 1988 - 1991- Indiana University School of MedicineClass of 1988
Certifications & Licensure
IN State Medical License 1991 - 2025
TX State Medical License 1989 - 1992
American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 8 citationsLong-term open-label safety study of galcanezumab in patients with episodic or chronic cluster headache.Robert Riesenberg, Charly Gaul, Chad E Stroud, Yan Dong, Mark E Bangs
Cephalalgia. 2022-10-01 - 13 citationsTolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment.Miguel J. A. Láinez, Jean Schoenen, Chad Stroud, Jennifer N. Bardos, Mark E. Bangs
Headache. 2021-11-22 - Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies.Mark E Bangs, David Kudrow, Shufang Wang, Tina M Oakes, Gisela M Terwindt
BMC Neurology. 2020-03-13
Professional Memberships
- Member
Industry Relationships
- Clinical Research Physician, Eli LillyGlobal Patient Safety
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
